Maze Therapeutics

Maze Therapeutics

At Maze, we envision a world where genetic insights inspire new medicines.

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Maze Therapeutics. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
160 people
Headquarters
South San Francisco, California
Founded
2018
Type
Privately Held
Total funding
$796.0M

Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. The company’s pipeline is led by two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease. Maze is based in South San Francisco.

Biopharma Biotechnology Genetics Therapeutics

Open roles at Maze Therapeutics